This effect is mainly used to activate certain coagulation factors in the clotting process and prevent certain bleeding diseases caused by low coagulation function.
| NO. | PubChem ID | CAS Number | Molecular Name | Efficacy | Efficacy_Chinese |
|---|---|---|---|---|---|
| 41 | 146808 | 94201-17-9 | 2-(8,8a-dimethyl-2,3,4,6,7,8-hexahydro-1H-naphthalen-2-yl)propan-2-ol | procoagulant | 促凝血 |
| 42 | 147299 | 29106-51-2 | (2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol | procoagulant | 促凝血 |
| 43 | 153441 | 0 | 5,8-dihydroxy-6,7-dimethoxy-2-phenylchromen-4-one | procoagulant | 促凝血 |
| 44 | 176911 | 0 | 5,7-dimethoxy-8-(3-methylbut-2-enyl)chromen-2-one | procoagulant | 促凝血 |
| 45 | 196729 | 0 | 6-[[17-hydroxy-17-[1-[5-hydroxy-4-(methoxymethoxy)-6-methyloxan-2-yl]oxyethyl]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyl-2H-pyran-5-one | procoagulant | 促凝血 |
| 46 | 222284 | 83-46-5 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | procoagulant | 促凝血 |
| 47 | 432922 | 0 | 2,3,12,15,16-pentahydroxy-9,13,17-trimethyl-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-9-ene-4,11-dione | procoagulant | 促凝血 |
| 48 | 440832 | 7690-51-9 | 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol | procoagulant | 促凝血 |
| 49 | 441893 | 472-11-7 | (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,14R,16R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14,16-diol | procoagulant | 促凝血 |
| 50 | 442085 | 0 | (1'S,3S,3aR,4R,6'S,7'R,7aR,9'S)-3,7'-dihydroxy-7a-methyl-10'-methylidenespiro[1,3,3a,5,6,7-hexahydro-2-benzofuran-4,5'-3-oxatricyclo[7.2.1.01,6]dodecane]-2',11'-dione | procoagulant | 促凝血 |